Total Payments
$7,332
2024 Payments
$935.19
Companies
31
Transactions
330
Medicare Patients
3,402
Medicare Billing
$227,527
Payment Breakdown by Category
Food & Beverage$7,209 (98.3%)
Education$122.95 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,209 | 328 | 98.3% |
| Education | $122.95 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,481 | 63 | $0 (2024) |
| Amgen Inc. | $761.55 | 32 | $0 (2023) |
| GENZYME CORPORATION | $700.70 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $674.69 | 34 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $596.23 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $587.56 | 26 | $0 (2024) |
| LEO Pharma Inc. | $331.35 | 18 | $0 (2024) |
| Lilly USA, LLC | $329.29 | 17 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $300.10 | 16 | $0 (2024) |
| Dermavant Sciences, Inc. | $220.36 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $935.19 | 39 | ABBVIE INC. ($334.37) |
| 2023 | $1,613 | 61 | AbbVie Inc. ($367.32) |
| 2022 | $1,398 | 57 | Novartis Pharmaceuticals Corporation ($305.72) |
| 2021 | $1,229 | 60 | GENZYME CORPORATION ($267.87) |
| 2020 | $862.09 | 42 | Amgen Inc. ($202.63) |
| 2019 | $535.47 | 29 | Celgene Corporation ($88.89) |
| 2018 | $326.94 | 17 | AbbVie, Inc. ($68.04) |
| 2017 | $432.95 | 25 | AbbVie, Inc. ($109.42) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Immunology | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Immunology | ||||||
| 09/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Immunology | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: IMMUNOLOGY | ||||||
| 08/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Dermatology | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Immunology | ||||||
| 07/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Dermatology | ||||||
| 07/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: DERMATOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 733 | 1,104 | $181,745 | $47,878 |
| 2022 | 9 | 829 | 1,292 | $207,146 | $55,102 |
| 2021 | 8 | 749 | 1,163 | $175,750 | $53,373 |
| 2020 | 11 | 1,091 | 1,667 | $208,685 | $71,174 |
Total Patients
3,402
Total Services
5,226
Medicare Billing
$227,527
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 285 | $59,665 | $18,463 | 30.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 104 | 111 | $38,430 | $9,529 | 24.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 121 | 147 | $22,460 | $6,761 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $15,660 | $4,291 | 27.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 43 | 44 | $10,050 | $3,307 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 65 | $10,875 | $2,651 | 24.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 89 | 378 | $20,855 | $2,002 | 9.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $3,750 | $874.41 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 266 | 328 | $65,480 | $20,828 | 31.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 104 | 126 | $42,475 | $10,796 | 25.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 143 | 168 | $25,480 | $7,170 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $18,825 | $5,549 | 29.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 54 | 57 | $12,695 | $4,198 | 33.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 60 | $10,530 | $2,490 | 23.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 113 | 451 | $25,115 | $2,419 | 9.6% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2022 | 12 | 17 | $4,011 | $1,049 | 26.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $2,535 | $603.57 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 246 | 294 | $52,960 | $20,518 | 38.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 105 | 127 | $39,470 | $11,352 | 28.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 82 | 82 | $19,140 | $6,316 | 33.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 115 | 151 | $21,345 | $6,297 | 29.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 64 | 74 | $11,670 | $3,165 | 27.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 40 | 41 | $8,435 | $3,027 | 35.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 83 | 380 | $19,580 | $2,065 | 10.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $3,150 | $633.31 | 20.1% |
About Dr. Daniel Viders, MD
Dr. Daniel Viders, MD is a Dermatology healthcare provider based in Auburn, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558354407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Viders, MD has received a total of $7,332 in payments from pharmaceutical and medical device companies, with $935.19 received in 2024. These payments were reported across 330 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,209).
As a Medicare-enrolled provider, Viders has provided services to 3,402 Medicare beneficiaries, totaling 5,226 services with total Medicare billing of $227,527. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Auburn, MA
- Active Since 08/25/2005
- Last Updated 11/28/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1558354407
Products in Payments
- DUPIXENT (Biological) $1,024
- SKYRIZI (Biological) $805.10
- Otezla (Drug) $736.38
- COSENTYX (Biological) $490.29
- TREMFYA (Drug) $382.98
- TALTZ (Drug) $329.29
- RINVOQ (Biological) $303.86
- VTAMA (Drug) $220.36
- ENSTILAR (Drug) $202.75
- Humira (Biological) $197.95
- REMICADE (Biological) $180.59
- OPZELURA (Drug) $175.81
- EUCRISA (Drug) $157.84
- Cimzia (Drug) $154.79
- ILUMYA (Biological) $152.93
- Enbrel (Biological) $127.71
- DUPIXENT (Drug) $126.75
- Erivedge (Biological) $119.23
- COSENTYX (Drug) $118.32
- Sotyktu (Drug) $116.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Auburn
Dr. Kevin Nash, Md, Phd, MD, PHD
Dermatology — Payments: $417,511
Dermatology $417,511
Dr. Rona Beth Holmes, Md, MD
Dermatology — Payments: $8,725
Dermatology $8,725
Dr. Joshua Cash, M.d, M.D
Dermatology — Payments: $7,697
Dermatology $7,697
Allison Mccormick, M.d, M.D
Dermatology — Payments: $4,095
Dermatology $4,095
Dr. Stephanie Lai, Md, MD
Dermatology — Payments: $3,464
Dermatology $3,464
John Person, Md, MD
Dermatology
Dermatology